Bio-Rad Laboratories, Inc. Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc.

BIO

Classifica tra le azioni #2168
Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules,... Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America. The company is organized into two primary divisions: Life Science and Clinical Diagnostics. The Life Science division is responsible for developing, manufacturing, and commercializing a diverse array of reagents, equipment, and laboratory instruments. These products are crucial for various research methodologies, biopharmaceutical manufacturing processes, and food quality testing. This segment focuses on specialized areas within the life sciences, including proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. Its clientele encompasses academic institutions (such as universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology firms, food producers, and food testing laboratories. In contrast, the Clinical Diagnostics division designs, produces, sells, and supports a comprehensive suite of test systems, informatics solutions, diagnostic kits, and specialized quality control products for clinical laboratories. This segment provides reagents, instruments, and software specifically tailored for particular niches within the in vitro diagnostics market. Its customer base includes reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. Beyond these core segments, Bio-Rad also offers systems and products designed to separate complex chemical and biological materials, as well as to identify, analyze, and purify their individual components. The company distributes its extensive product portfolio through a combination of its direct sales force and a network of third-party distributors, agents, brokers, and resellers.
Prezzo delle azioni
$352.07
Ultima sincronizzazione: 2026-10-19
Capitalizzazione di mercato
$9.41B
Variazione (1 giorno)
-0.23%
Variazione (1 anno)
9.37%
Paese
US
Scambia Bio-Rad Laboratories, Inc. (BIO)

Categoria

Healthcare
Numero di azioni in circolazione per Bio-Rad Laboratories, Inc. (BIO)
Numero di azioni in circolazione al June 2026: 26.75M
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Bio-Rad Laboratories, Inc., il numero attuale di azioni in circolazione è 26.75M. Alla fine del December 2024, la società aveva 28.21M azioni in circolazione. Il numero di azioni in circolazione è solitamente influenzato da split azionari e riacquisti.
Storico delle azioni in circolazione di Bio-Rad Laboratories, Inc. (BIO) dal 2000 al 2026
Azioni in circolazione alla fine di ogni anno
Anno Azioni in circolazione Cambia
2026 (TTM) 26.75M -1.90%
2025 27.26M -3.37%
2024 28.21M -3.41%
2023 29.21M -1.93%
2022 29.79M -0.15%
2021 29.83M 0.21%
2020 29.77M -0.25%
2019 29.84M 0.02%
2018 29.84M 0.61%
2017 29.66M 0.73%
2016 29.44M 0.87%
2015 29.19M 1.07%
2014 28.88M 1.01%
2013 28.59M 1.05%
2012 28.29M 0.92%
2011 28.03M 1.32%
2010 27.67M 0.95%
2009 27.40M 1.08%
2008 27.11M 1.48%
2007 26.72M 1.29%
2006 26.38M 1.20%
2005 26.06M 1.32%
2004 25.72M 1.21%
2003 25.42M 1.12%
2002 25.13M 1.97%
2001 24.65M 0.93%
2000 24.42M 0.00%
Azioni in circolazione per aziende simili o concorrenti
Azienda Azioni in circolazione Differenza Il paese
1.74B 6,417.05%
US
1.28B 4,693.61%
IE
383.50M 1,333.86%
US
1.48B 5,424.56%
US
- -
DE